Crossmark

Role of CTLA-4 blockade and dacarbazine therapy following anti-PD-1 resistance in melanoma

Published Online: 2026-03-16

Authors

Urbonas, Vincas

Dulskas, Audrius
License Information

Text and Data Mining valid from 2026-03-16

Version of Record valid from 2026-04-23
More Information

Article History

Received: 29 November 2025

Accepted: 9 March 2026

First Online: 16 March 2026

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current